Annual Total Assets
$653.70 M
-$47.59 M-6.79%
December 31, 2023
Summary
- As of February 25, 2025, RXRX annual total assets is $653.70 million, with the most recent change of -$47.59 million (-6.79%) on December 31, 2023.
- During the last 3 years, RXRX annual total assets has risen by +$355.11 million (+118.93%).
- RXRX annual total assets is now -6.79% below its all-time high of $701.29 million, reached on December 31, 2022.
Performance
RXRX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$726.50 M
-$49.36 M-6.36%
September 30, 2024
Summary
- As of February 25, 2025, RXRX quarterly total assets is $726.50 million, with the most recent change of -$49.36 million (-6.36%) on September 30, 2024.
- Over the past year, RXRX quarterly total assets has stayed the same.
- RXRX quarterly total assets is now -6.36% below its all-time high of $775.86 million, reached on June 30, 2024.
Performance
RXRX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
RXRX Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.8% | 0.0% |
| 3 y3 years | +118.9% | +3.6% |
| 5 y5 years | +544.5% | +3.6% |
RXRX Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.8% | +7.1% | -6.4% | +30.2% |
| 5 y | 5-year | -6.8% | +544.5% | -6.4% | +167.2% |
| alltime | all time | -6.8% | +544.5% | -6.4% | +167.2% |
Recursion Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $726.50 M(-6.4%) |
| Jun 2024 | - | $775.86 M(+39.1%) |
| Mar 2024 | - | $557.85 M(-14.7%) |
| Dec 2023 | $653.70 M(-6.8%) | $653.70 M(+3.6%) |
| Sep 2023 | - | $630.83 M(-5.4%) |
| Jun 2023 | - | $666.70 M(+6.3%) |
| Mar 2023 | - | $627.37 M(-10.5%) |
| Dec 2022 | $701.29 M | $701.29 M(+14.7%) |
| Sep 2022 | - | $611.53 M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $672.51 M(-8.4%) |
| Mar 2022 | - | $734.32 M(+20.3%) |
| Dec 2021 | $610.35 M(+104.4%) | $610.35 M(-7.3%) |
| Sep 2021 | - | $658.61 M(-5.7%) |
| Jun 2021 | - | $698.59 M(+156.9%) |
| Mar 2021 | - | $271.94 M(-8.9%) |
| Dec 2020 | $298.58 M(+194.4%) | - |
| Dec 2020 | - | $298.58 M |
| Dec 2019 | $101.43 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual total assets year-on-year change?
- What is Recursion Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly total assets year-on-year change?
What is Recursion Pharmaceuticals annual total assets?
The current annual total assets of RXRX is $653.70 M
What is the all time high annual total assets for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total assets is $701.29 M
What is Recursion Pharmaceuticals annual total assets year-on-year change?
Over the past year, RXRX annual total assets has changed by -$47.59 M (-6.79%)
What is Recursion Pharmaceuticals quarterly total assets?
The current quarterly total assets of RXRX is $726.50 M
What is the all time high quarterly total assets for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total assets is $775.86 M
What is Recursion Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, RXRX quarterly total assets has changed by $0.00 (0.00%)